HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Guo-Wei He Tea E. Acuff William H. Ryan Michael J. Mack Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by He, G.-W. Articles by Mack, M. J. Search for Related Content PubMed PubMed Citation Articles by He, G.-W. Articles by Mack, M. J.

J Thorac Cardiovasc Surg 1994;108:741-746
© 1994 Mosby, Inc.

SURGERY FOR ACQUIRED HEART DISEASE

Middle and proximal sections of the human internal mammary artery are not "passive conduits"

Portland, Ore., and Dallas, Tex.

Received for publication Dec. 23, 1993. Accepted for publication May 2, 1994. Address for reprints: Guo-Wei He, MD, PhD, Director, Cardiovascular Research, the Albert Starr Academic Center for Cardiac Surgery, St. Vincent Heart Institute, Suite 240, 9155, Barnes Rd., Portland, OR 97225.

Abstract

Recent studies have shown that blood flow through the internal mammary artery graft is inadequate for maximal exercise and that hypoperfusion may be worsened by high-dose vasopressor therapy that could further reduce arterial graft flow. Histologic studies have suggested that the human internal mammary artery is an elastic "passive conduit" along the majority of its length. However, although the pharmacologic reactivity at the distal section of the internal mammary artery has been extensively studied, this evaluation has never been done at the middle and proximal sections. It is extremely important to understand the contractility at the midsection of the internal mammary artery because, in a critical situation, any contraction may further reduce the internal mammary artery flow. The present study was designed to investigate the following: (1) Is it true that the pharmacologic reactivity of the human internal mammary artery is different among various sections? and (2) Is the human internal mammary artery a nonreactive "passive conduit" at its most important area used as the graft—the middle and the proximal sections? One hundred six human internal mammary artery ring segments taken from patients who underwent internal mammary artery grafting procedures (29 from the proximal, 38 from the middle, and 39 from the distal sections) were studied in the organ bath under a physiologic pressure. Concentration-response curves were established for norepinephrine, endothelin-1, U46619, potassium, and glyceryl trinitrate (precontracted with 10 nmol/L U46619). Contraction forces were standardized (in grams per millimeter circumference) at a pressure of 100 mm Hg. The contraction force was greater in the distal section than in other sections for norepinephrine (p = 0.002) and endothelin-1 (p = 0.04). No differences were seen for potassium, U46619, or glyceryl trinitrate, whereas the effective concentration inducing 50% of maximal response for U46619 was 100-fold lower in the distal than in the middle section (9.06 ± 0.34 versus 7.06 ± 0.48 -log M; p = 0.01) indicating higher sensitivity in the distal section. This study for the first time shows various reactivity along the full length of the human internal mammary artery and shows that the distal section is the most reactive part of the graft. However, although the middle and the proximal sections are less reactive to some vasoconstrictors (norepinephrine and endothelin-1), it is not a "passive conduit" and it contracts with all four vasoconstrictors tested. The contractility at the midsection should be fully appreciated because, under critical postoperative situations (hypoperfusion) or during exercise with marginal flow, the ability of these sections to contract in response to vasoconstrictors may become clinically detrimental and require pharmacologic therapy. (J THORACCARDIOVASCSURG1994;108:741-6)

This article has been cited by other articles:

				B. Rozec, S. Serpillon, G. Toumaniantz, C. Seze, Y. Rautureau, O. Baron, J. Noireaud, and C. Gauthier Characterization of Beta3-Adrenoceptors in Human Internal Mammary Artery and Putative Involvement in Coronary Artery Bypass Management J. Am. Coll. Cardiol., July 19, 2005; 46(2): 351 - 359. [Abstract] [Full Text] [PDF]

				M. Hata, M. Shiono, T. Inoue, A. Sezai, N. Negishi, and Y. Sezai Midterm results of coronary artery bypass graft surgery with internal thoracic artery under low free-flow conditions Ann. Thorac. Surg., August 1, 2004; 78(2): 477 - 480. [Abstract] [Full Text] [PDF]

				Y. Tabel, H. Hepaguslar, C. Erdal, H. Catalyurek, U. Acikel, Z. Elar, and O. Aslan Diltiazem provides higher internal mammary artery flow than nitroglycerin during coronary artery bypass grafting surgery Eur. J. Cardiothorac. Surg., April 1, 2004; 25(4): 553 - 559. [Abstract] [Full Text] [PDF]

				M. Hata, J. S. Raman, M. Shiono, N. Negishi, Y. Sezai, E. D. Croce, and B. F. Buxton Apical transthoracic Doppler echocardiography can be useful for analysis of postoperative early function of the left internal thoracic artery J. Thorac. Cardiovasc. Surg., February 1, 2002; 123(2): 385 - 387. [Full Text] [PDF]

				M. Hata, M. Shiono, Y. Orime, S. Yagi, T. Yamamoto, H. Okumura, S.-i. Kimura, A. Sezai, S. Kashiwazaki, S. Choh, et al. CLINICAL RESULTS OF CORONARY ARTERY BYPASS GRAFTING WITH USE OF THE INTERNAL THORACIC ARTERY UNDER LOW FREE FLOW CONDITIONS J. Thorac. Cardiovasc. Surg., January 1, 2000; 119(1): 125 - 129. [Abstract] [Full Text] [PDF]

				F. L. Rosenfeldt, G.-W. He, B. F. Buxton, and J. A. Angus Pharmacology of coronary artery bypass grafts Ann. Thorac. Surg., March 1, 1999; 67(3): 878 - 888. [Abstract] [Full Text] [PDF]

				G.-W. He Arterial grafts for coronary artery bypass grafting: biological characteristics, functional classification, and clinical choice Ann. Thorac. Surg., January 1, 1999; 67(1): 277 - 284. [Abstract] [Full Text] [PDF]

				G.-W. He and C.-Q. Yang Radial Artery Has Higher Receptor-Mediated Contractility but Similar Endothelial Function Compared With Mammary Artery Ann. Thorac. Surg., May 1, 1997; 63(5): 1346 - 1352. [Abstract] [Full Text]

				R. Lundblad, O. Moen, and E. Fosse Endothelin-1 and Neutrophil Activation During Heparin-Coated Cardiopulmonary Bypass Ann. Thorac. Surg., May 1, 1997; 63(5): 1361 - 1367. [Abstract] [Full Text]

				J. A. M. van Son, F. M. Smedts, C.-Q. Yang, M. Mravunac, V. Falk, F. W. Mohr, and G.-W. He Morphometric Study of the Right Gastroepiploic and Inferior Epigastric Arteries Ann. Thorac. Surg., March 1, 1997; 63(3): 709 - 715. [Abstract] [Full Text]

				D. Arnaudov, A. J. Cohen, D. Zabeeda, E. Hauptman, L. Sasson, A. Schachner, and S. Ezra Effect of Systemic Vasodilators on Internal Mammary Flow During Coronary Bypass Grafting Ann. Thorac. Surg., December 1, 1996; 62(6): 1816 - 1819. [Abstract] [Full Text]

				Yijiang Chen, Bo Liu, and A. Belboul Cardiopulmonary bypass support for treatment of left ventricular failure following coronary artery bypass grafting: the effects on epicardial microflow and graft flow Perfusion, September 1, 1996; 11(5): 407 - 414. [Abstract] [PDF]

				G.-W. He and C.-Q. Yang Comparison among arterial grafts and coronary artery: An attempt at functional classification J. Thorac. Cardiovasc. Surg., April 1, 1995; 109(4): 707 - 715. [Abstract] [Full Text]

				G.-W. He, C.-Q. Yang, and A. Starr Overview of the Nature of Vasoconstriction in Arterial Grafts for Coronary Operations Ann. Thorac. Surg., March 1, 1995; 59(3): 676 - 683. [Abstract] [Full Text]